file

Jordan M. Winter, MD, FACS

Contact Dr. Winter

1025 Walnut Street
College Building, Suite 605
Philadelphia, PA 19107

(215) 955-9402
(215) 923-6609 fax

Most Recent Peer-reviewed Publications

  1. The Combination of Pancreas Texture and Postoperative Serum Amylase in Predicting Pancreatic Fistula Risk
  2. The combination of pancreas texture and postoperative serum amylase in predicting pancreatic fistula risk
  3. Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer
  4. A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2
  5. Common Hepatic Artery Abutment or Encasement Is an Adverse Prognostic Factor in Patients with Borderline and Unresectable Pancreatic Cancer
  6. Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis from the International Phase III ESPAC-3 Clinical Trial
  7. Microscopic lymphovascular invasion is an independent predictor of survival in resected pancreatic ductal adenocarcinoma
  8. Total parenteral nutrition in patients following pancreaticoduodenectomy: lessons from 1184 patients
  9. Posttranscriptional regulation of PARG mRNA by HuR facilitates DNA repair and resistance to PARP inhibitors
  10. A Prospective Randomized Multicenter Trial of Distal Pancreatectomy with and Without Routine Intraperitoneal Drainage
  11. Posttranscriptional upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells
  12. CRISPR knockout of the HuR gene causes a xenograft lethal phenotype
  13. Pneumonia is associated with a high risk of mortality after pancreaticoduodenectomy
  14. Increasing resident utilization and recognition of the critical view of safety during laparoscopic cholecystectomy: a pilot study from an academic medical center
  15. Genetics of Pancreatic Cancer and Its Implications on Therapy
  16. WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner
  17. Pancreatic Cancer: A Review
  18. The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells
  19. The landscape of pancreatic cancer therapeutic resistance mechanisms
  20. HuR contributes to TRAIL resistance by restricting death receptor 4 expression in pancreatic cancer cells